T cell-independent rescue of B lymphocytes from peripheral immune tolerance

Science

Volumn 287, Issue 5462, 2000, Pages 2501-2503

  Kouskoff, Valerie ^a,c   Lacaud, Georges ^a,c   Nemazee, David ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTOPOIESIS; LYMPHOPOIESIS; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, T-INDEPENDENT; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; BONE MARROW; CLONAL DELETION; CROSS REACTIONS; H-2 ANTIGENS; IMMUNIZATION; IMMUNOGLOBULIN M; LIVER; LYMPH NODES; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MOLECULAR MIMICRY; RECEPTORS, ANTIGEN, B-CELL; SELF TOLERANCE; T-LYMPHOCYTES;

ANIMALIA;

EID: 0034737645     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.287.5462.2501     Document Type: Article

References (51)

1. T. J. Vyse and J. A. Todd, Cell 85, 311 (1996).
2. N. Sarvetnick et al., Nature 346, 844 (1990); D. Gu et al., J. Exp. Med. 181, 547 (1995); W. R. Heath et al., Nature 359, 547 (1992).
3. N. Sarvetnick et al., Nature 346, 844 (1990); D. Gu et al., J. Exp. Med. 181, 547 (1995); W. R. Heath et al., Nature 359, 547 (1992).
4. N. Sarvetnick et al., Nature 346, 844 (1990); D. Gu et al., J. Exp. Med. 181, 547 (1995); W. R. Heath et al., Nature 359, 547 (1992).
5. M. B. A. Oldstone, Cell 50, 819 (1987); K. W. Wucherpfennig and J. L. Strominger, Cell 80, 695 (1995); S. D. Miller et al., Nature Med. 3, 1133 (1997); P. V. Lehmann, T. Forsthuber, A. Miller, E. E. Sercarz, Nature 358, 155 (1992); B. L. McRae, C. L. Vanderlugt, C. M. Dal, S. D. Miller, J. Exp. Med. 182, 75 (1995); D. F. Tough and J. Sprent, Immunol Rev. 150, 129 (1996); M. Yu, J. M. Johnson, V. K. Tuohy, J. Exp. Med. 183, 1777 (1996)
6. M. B. A. Oldstone, Cell 50, 819 (1987); K. W. Wucherpfennig and J. L. Strominger, Cell 80, 695 (1995); S. D. Miller et al., Nature Med. 3, 1133 (1997); P. V. Lehmann, T. Forsthuber, A. Miller, E. E. Sercarz, Nature 358, 155 (1992); B. L. McRae, C. L. Vanderlugt, C. M. Dal, S. D. Miller, J. Exp. Med. 182, 75 (1995); D. F. Tough and J. Sprent, Immunol Rev. 150, 129 (1996); M. Yu, J. M. Johnson, V. K. Tuohy, J. Exp. Med. 183, 1777 (1996)
7. M. B. A. Oldstone, Cell 50, 819 (1987); K. W. Wucherpfennig and J. L. Strominger, Cell 80, 695 (1995); S. D. Miller et al., Nature Med. 3, 1133 (1997); P. V. Lehmann, T. Forsthuber, A. Miller, E. E. Sercarz, Nature 358, 155 (1992); B. L. McRae, C. L. Vanderlugt, C. M. Dal, S. D. Miller, J. Exp. Med. 182, 75 (1995); D. F. Tough and J. Sprent, Immunol Rev. 150, 129 (1996); M. Yu, J. M. Johnson, V. K. Tuohy, J. Exp. Med. 183, 1777 (1996)
8. M. B. A. Oldstone, Cell 50, 819 (1987); K. W. Wucherpfennig and J. L. Strominger, Cell 80, 695 (1995); S. D. Miller et al., Nature Med. 3, 1133 (1997); P. V. Lehmann, T. Forsthuber, A. Miller, E. E. Sercarz, Nature 358, 155 (1992); B. L. McRae, C. L. Vanderlugt, C. M. Dal, S. D. Miller, J. Exp. Med. 182, 75 (1995); D. F. Tough and J. Sprent, Immunol Rev. 150, 129 (1996); M. Yu, J. M. Johnson, V. K. Tuohy, J. Exp. Med. 183, 1777 (1996)
9. M. B. A. Oldstone, Cell 50, 819 (1987); K. W. Wucherpfennig and J. L. Strominger, Cell 80, 695 (1995); S. D. Miller et al., Nature Med. 3, 1133 (1997); P. V. Lehmann, T. Forsthuber, A. Miller, E. E. Sercarz, Nature 358, 155 (1992); B. L. McRae, C. L. Vanderlugt, C. M. Dal, S. D. Miller, J. Exp. Med. 182, 75 (1995); D. F. Tough and J. Sprent, Immunol Rev. 150, 129 (1996); M. Yu, J. M. Johnson, V. K. Tuohy, J. Exp. Med. 183, 1777 (1996)
10. M. B. A. Oldstone, Cell 50, 819 (1987); K. W. Wucherpfennig and J. L. Strominger, Cell 80, 695 (1995); S. D. Miller et al., Nature Med. 3, 1133 (1997); P. V. Lehmann, T. Forsthuber, A. Miller, E. E. Sercarz, Nature 358, 155 (1992); B. L. McRae, C. L. Vanderlugt, C. M. Dal, S. D. Miller, J. Exp. Med. 182, 75 (1995); D. F. Tough and J. Sprent, Immunol Rev. 150, 129 (1996); M. Yu, J. M. Johnson, V. K. Tuohy, J. Exp. Med. 183, 1777 (1996)
11. M. B. A. Oldstone, Cell 50, 819 (1987); K. W. Wucherpfennig and J. L. Strominger, Cell 80, 695 (1995); S. D. Miller et al., Nature Med. 3, 1133 (1997); P. V. Lehmann, T. Forsthuber, A. Miller, E. E. Sercarz, Nature 358, 155 (1992); B. L. McRae, C. L. Vanderlugt, C. M. Dal, S. D. Miller, J. Exp. Med. 182, 75 (1995); D. F. Tough and J. Sprent, Immunol Rev. 150, 129 (1996); M. Yu, J. M. Johnson, V. K. Tuohy, J. Exp. Med. 183, 1777 (1996)
12. P. S. Ohashi et al., Cell 65, 305 (1991); A. J. Caton, J. R. Swartzentruber, A. L. Kuhl, S. R. Carding, S. E. Stark, J. Exp. Med. 183, 13 (1996).
13. P. S. Ohashi et al., Cell 65, 305 (1991); A. J. Caton, J. R. Swartzentruber, A. L. Kuhl, S. R. Carding, S. E. Stark, J. Exp. Med. 183, 13 (1996).
14. M. J. Mamula, Immunol. Rev. 164, 231 (1998);
15. R. B. Fritz, C. H. Chou, D. E. McFarlin, J. Immunol. 130, 1024 (1983);
16. S. Akkaraju, K. Canaan, C. C. Goodnow, J. Exp. Med. 186, 2005 (1997)
17. L. Hang et al., J. Exp. Med. 157, 874 (1983); M. G. McHeyzer-Williams and G. J. V. Nossal, J. Immunol. 41, 4118 (1988); M. Rocken, J. F. Urban, E. M. Shevach, Nature 359, 79 (1992).
18. L. Hang et al., J. Exp. Med. 157, 874 (1983); M. G. McHeyzer-Williams and G. J. V. Nossal, J. Immunol. 41, 4118 (1988); M. Rocken, J. F. Urban, E. M. Shevach, Nature 359, 79 (1992).
19. L. Hang et al., J. Exp. Med. 157, 874 (1983); M. G. McHeyzer-Williams and G. J. V. Nossal, J. Immunol. 41, 4118 (1988); M. Rocken, J. F. Urban, E. M. Shevach, Nature 359, 79 (1992).
20. C. C. Goodnow, R. Brink, E. Adams, Nature 352, 532 (1991).
21. D. A. Fulcher et al., J. Exp. Med. 183, 2313 (1996); M. P. Cooke et al., J. Exp. Med. 179, 425 (1994).
22. D. A. Fulcher et al., J. Exp. Med. 183, 2313 (1996); M. P. Cooke et al., J. Exp. Med. 179, 425 (1994).
23. J. G. Cyster and C. C. Goodnow, Immunity 3, 691 (1995).
24. P. Bretscher and M. Cohn, Science 169, 1042 (1970).
25. J. J. Mond, A. Lees, C. M. Snapper, Annu. Rev. Immunol. 13, 655 (1995).
26. K. Ozato, N. Mayer, D. H. Sachs, J. Immunol. 124, 533 (1980).
27. D. M. Russell et al., Nature 354, 308 (1991).
28. D. A. Nemazee and K. Burki, Nature 337, 562 (1989).
29. To generate nondeleting mice (3-83 ND mice), we backcrossed 3-83 transgenic mice (13), which express IgM and IgD forms of the 3-83 antibody, a minimum of 10 times onto a B10,D2nSn/J background.
30. G. Morahan et al., Proc. Natl. Acad. Sci. U.S.A. 86, 3782 (1989).
31. G. Schonrich et al., Int. Immunol. 4, 581 (1992).
32. b double Tg mice presented a peripheral deletion phonotype similar to those described using 3-83 mice crossed to mice expressing Kb in the liver under the control of the sheep metallothionein promoter (13).
33. V. Kouskoff et al., J. Exp. Med. 188, 1453 (1998); V. Kouskoff et al., unpublished data.
34. V. Kouskoff et al., J. Exp. Med. 188, 1453 (1998); V. Kouskoff et al., unpublished data.
35. Phage was purified as described (19), and mice were immunized with 300 μg of phage intraperitoneally (ip) at day 0. Anti-IL-7 (IM25) was prepared and used as described (30). Anti-CD4 (GK1.5) was obtained from ascites and injected at a dose of 0.5 mg per mouse per day. Analysis of 3-83 in the sera was performed using plates coated with rat 3-83 idiotypic antibody (54.1) at 5 μg/ml, as described (19).
36. A. M. Krieg et al., Nature 374, 546 (1995); V. Kouskoff, A. Krieg, D. Nemazee, unpublished data.
37. A. M. Krieg et al., Nature 374, 546 (1995); V. Kouskoff, A. Krieg, D. Nemazee, unpublished data.
38. 3. The following antibody reagents were used: mouse anti-IgM conjugated with fluorescein isothiocyanate (FITC) (Zymed), mouse anti-B220 conjugated with phycoerythrin (PE) (Caltag), mouse anti-CD8 conjugated with FITC, and mouse anti-CD4 conjugated with PE (Pharmingen). Flow cytometric analysis was done with a FacScan (Becton Dickinson) and the data were analyzed by Cell Quest software.
39. Spleens were flash-frozen in O.C.T. embedding medium (Miles), and 6-μm sections were cut and fixed in acetone. Serial sections were blocked for 10 min with PBS and 10% fetal calf serum, incubated with 2.4G2 culture supernatant for 30 min, then stained for 30 min with PE-labeled anti-B220 and FITC-labeled IgM, idiotype, or isotype control monoclonal antibodies.
40. Plasma transaminase levels were analyzed at days 0, 4, and 8 after immunization and were not altered in a comparison of three PBS-injected, five Pwt-injected, and four P31-immunized PD mice (V. Kouskoff, unpublished data).
41. K. H. Grabstein et al., J. Exp. Med. 178, 257 (1993).
42. E. Spanopoulou et al., Genes Dev. 8, 1030 (1994).
43. C. Leclerc, A. Charbit, P. Martineau, E. Deriaud, M. Hofnung, J. Immunol. 147, 3545 (1991); S. X. Qin et al., Eur. J. Immunol. 20, 2737 (1990); F. S. Jin et al., J. Immunol. 146, 1806 (1991).
44. C. Leclerc, A. Charbit, P. Martineau, E. Deriaud, M. Hofnung, J. Immunol. 147, 3545 (1991); S. X. Qin et al., Eur. J. Immunol. 20, 2737 (1990); F. S. Jin et al., J. Immunol. 146, 1806 (1991).
45. C. Leclerc, A. Charbit, P. Martineau, E. Deriaud, M. Hofnung, J. Immunol. 147, 3545 (1991); S. X. Qin et al., Eur. J. Immunol. 20, 2737 (1990); F. S. Jin et al., J. Immunol. 146, 1806 (1991).
46. E. Szomolanyi-Tsuda and R. M. Welsh, Curr. Opin. Immunol. 10, 431 (1998); M. F. Bachmann and R. M. Zinkernagel, Annu. Rev. Immunol. 15, 235 (1997).
47. E. Szomolanyi-Tsuda and R. M. Welsh, Curr. Opin. Immunol. 10, 431 (1998); M. F. Bachmann and R. M. Zinkernagel, Annu. Rev. Immunol. 15, 235 (1997).
48. K. Bachmaier et al., Science 283, 1335 (1999); Z.-S. Zhao, F. Granucci, L. Yeh, P. A. Schaffer, H. Cantor, Science 279, 1344 (1998).
49. K. Bachmaier et al., Science 283, 1335 (1999); Z.-S. Zhao, F. Granucci, L. Yeh, P. A. Schaffer, H. Cantor, Science 279, 1344 (1998).
50. D. Melamed, J. A. Kench, K. Grabstein, A. Rolink, D. Nemazee, J. Immunol. 159, 1233 (1997).
51. b mice.